- Home
- UTSI vs ABVC Comparison
UTSI vs ABVC Comparison
Compare UTSI & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTSI
- ABVC
- Stock Information
- Founded
- UTSI 1991
- ABVC 2015
- Country
- UTSI China
- ABVC United States
- Employees
- UTSI N/A
- ABVC N/A
- Industry
- UTSI Telecommunications Equipment
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- UTSI Telecommunications
- ABVC Health Care
- Exchange
- UTSI Nasdaq
- ABVC Nasdaq
- Market Cap
- UTSI 24.6M
- ABVC 22.1M
- IPO Year
- UTSI 2000
- ABVC N/A
- Fundamental
- Price
- UTSI $2.67
- ABVC $1.15
- Analyst Decision
- UTSI
- ABVC
- Analyst Count
- UTSI 0
- ABVC 0
- Target Price
- UTSI N/A
- ABVC N/A
- AVG Volume (30 Days)
- UTSI 1.8K
- ABVC 298.3K
- Earning Date
- UTSI 06-03-2025
- ABVC 04-30-2025
- Dividend Yield
- UTSI N/A
- ABVC N/A
- EPS Growth
- UTSI N/A
- ABVC N/A
- EPS
- UTSI N/A
- ABVC N/A
- Revenue
- UTSI $10,878,000.00
- ABVC $508,383.00
- Revenue This Year
- UTSI N/A
- ABVC $735.18
- Revenue Next Year
- UTSI N/A
- ABVC N/A
- P/E Ratio
- UTSI N/A
- ABVC N/A
- Revenue Growth
- UTSI N/A
- ABVC 1904.43
- 52 Week Low
- UTSI $1.84
- ABVC $0.40
- 52 Week High
- UTSI $3.22
- ABVC $1.79
- Technical
- Relative Strength Index (RSI)
- UTSI 60.83
- ABVC 49.05
- Support Level
- UTSI $2.43
- ABVC $1.14
- Resistance Level
- UTSI $2.77
- ABVC $1.52
- Average True Range (ATR)
- UTSI 0.08
- ABVC 0.18
- MACD
- UTSI -0.00
- ABVC -0.03
- Stochastic Oscillator
- UTSI 66.67
- ABVC 5.88
About UTSI UTStarcom Holdings Corp.
UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.